Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – People with HIV treated at outpatient clinics may be at an increased risk of bone fractures, according to a new study published in…
NEW YORK (Reuters Health) – In a new study testing the efficacy of atomoxetine in young children with ADHD, kids on the drug improved on some measures of…
NEW YORK (Reuters Health) – The combination of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB) is often prescribed for elderly patients who do not…
WASHINGTON (from The George Washington University) – A new study by The George Washington University School of Medicine and Health Sciences, that will be published in the Journal…
Lena Edwards, MD, internist, Balance Health & Wellness Center, discusses stress and anxiety. Depression and anxiety are directly linked to HPA (hypothalamic-pituitary-adrenal axis) and increase in cortisol. SSRIs…
NEW YORK (Reuters Health) – Compared with fibrinolytic therapy, primary percutaneous coronary intervention (PCI) in patients with acute MI is associated with a significant reduction in early mortality,…
NEW YORK (Reuters Health) – Percutaneous balloon angioplasty with stenting of renal artery stenosis (RAS) added to medical therapy reduces the need for antihypertensive medication slightly, but otherwise…
NEW YORK (Reuters Health) – Among symptomatic children with chronic gastritis associated with Helicobacter pylori infection, the condition does not resolve spontaneously, and chronic inflammation tends to increase…
NEW YORK (Reuters Health) – Long-term treatment with the atypical antipsychotic asenapine prevents relapse of schizophrenia and is well tolerated, according to a report in the Journal of…
NEW YORK (Reuters Health) – A review published by the Cochrane Library concludes that artesunate should replace quinine as the standard treatment for severe malaria. Dr. David Sinclair,…
